Alyssa Halper, Belen Sanchez, J. Hodges
Jul 1, 2019
Citations
0
Influential Citations
14
Citations
Quality indicators
Journal
Clinical Endocrinology
Abstract
Anastrozole, an aromatase inhibitor, has been used off‐label in males with short stature to delay bone maturation. No studies have examined anastrozole's effect on bone mineral density (BMD) or body composition in children with congenital adrenal hyperplasia (CAH) due to 21‐hydroxylase deficiency. Our objective was to evaluate anastrozole's effect on BMD and visceral adipose tissue (VAT) in children with CAH.